DETAILED ACTION
Notice of Pre-AIA or AIA Status
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
Priority
Receipt is acknowledged of certified copies of papers required by 37 CFR 1.55.
Claim Rejections - 35 USC § 103
In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status.
The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action:
A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made.
Claim(s) 1-8 is/are rejected under 35 U.S.C. 103 as being unpatentable over Miyano (2018/0371276) (hereinafter Miyano) in view of Aoki et al. (WO 2022/085246 A1) (hereinafter Aoki et al.).
Regarding Claim 1, Miyano teaches an actinic radiation-curable inkjet ink [Paragraphs 0011-0012], comprising: a polymerizable compound (A) that polymerizes upon irradiation with actinic radiation [Paragraphs 0012-0014, 0031, 0049-0050]; a photopolymerization initiator (B) [Paragraphs 0012, 0014]; and a gelling agent (C) [Paragraph 0016], wherein the polymerizable compound (A) contains an amine-modified polymerizable compound (A1) [Paragraphs 0049-0050, 0065].
Miyano fails to explicitly teach the photopolymerization initiator (B) contains ethoxy (2,4,6-(trimethylbenzoyl)phenylphosphine oxide.
Aoki et al. teaches the photopolymerization initiator (B) contains ethoxy (2,4,6-(trimethylbenzoyl)phenylphosphine oxide [Abstract].
It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to provide the photopolymerization initiator (B) contains ethoxy (2,4,6-(trimethylbenzoyl)phenylphosphine oxide as taught by Miyano as modified for Aoki et al. for the purposes of providing a surface with scratch resistance [Aoki et al., “Use of ink composition”].
Regarding Claim 2, Miyano teaches the actinic radiation-curable inkjet ink [Paragraphs 0011-0012], wherein a content of the photopolymerization initiator (B) is 3% by mass or more and 10% by mass or less based on a total mass of the inkjet ink [Paragraph 0057].
Regarding Claim 3, Miyano teaches the actinic radiation-curable inkjet ink [Paragraphs 0011-0012], wherein a content of the amine-modified polymerizable compound (A1) is more than 0% by mass and 20% by mass or less based on a total mass of the inkjet ink [Paragraph 0068].
Regarding Claim 4, Miyano teaches the actinic radiation-curable inkjet ink [Paragraphs 0011-0012].
Miyano fails to explicitly teach wherein a ratio of a content of the amine-modified polymerizable compound (A1) to a content of the photopolymerization initiator (B) is more than 0 and 8 or less, the ratio being a ratio (A1/B).
Miyano further teaches the content of the amine-modified polymerizable compound (A1) is 0.5% to 10%, more preferably 0.5% to 6% [Paragraph 0068] and the content of the photopolymerization initiator (B) is 0.01% to 10%, more preferably 2% to 8% [Paragraph 0057].
Using the above-mentioned range, the ratio of a content of amine-modified polymerizable compound (A1) to a content of the photopolymerization initiator (B) is 0.25 to 0.75, which is more than 0 and less than 8.
Regarding Claim 5, Miyano teaches the actinic radiation-curable inkjet ink [Paragraphs 0011-0012].
Miyano fails to explicitly teach wherein a ratio of a content of the amine-modified polymerizable compound (A1) to a content of the photopolymerization initiator (B) is more than 0 and 2 or less, the ratio being a ratio (A1/B).
Miyano further teaches the content of the amine-modified polymerizable compound (A1) is 0.5% to 10%, more preferably 0.5% to 6% [Paragraph 0068] and the content of the photopolymerization initiator (B) is 0.01% to 10%, more preferably 2% to 8% [Paragraph 0057].
Using the above-mentioned range, the ratio of a content of amine-modified polymerizable compound (A1) to a content of the photopolymerization initiator (B) is 0.25 to 0.75, which is more than 0 and less than 2.
Regarding Claim 6, Miyano teaches the actinic radiation-curable inkjet ink [Paragraphs 0011-0012], wherein a content of the gelling agent (C) is 0.5% by mass or more and 10% by mass or less based on a total mass of the inkjet ink [Paragraphs 0018 and 0106].
Regarding Claim 7, Miyano teaches the actinic radiation-curable inkjet ink [Paragraphs 0011-0012], wherein the photopolymerization initiator (B) contains bis(2,4,6-(trimethylbenzoyl)phenylphosphine oxide or diphenyl(2,4,6-(trimethylbenzoyl)phenylphosphine oxide [Paragraph 0054].
Regarding Claim 8, Miyano teaches a method for producing a cured film, the method comprising: applying the inkjet ink according to claim 1 to a base material [Paragraphs 0024-0025]; and irradiating the applied inkjet ink with actinic radiation [Paragraph 0026].
Conclusion
Any inquiry concerning this communication or earlier communications from the examiner should be directed to LISA SOLOMON whose telephone number is (571)272-1701. The examiner can normally be reached Monday - Friday, 9:30am -6pm, EST.
Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Douglas Rodriguez can be reached at (571) 431-0716. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/LISA SOLOMON/Primary Examiner, Art Unit 2853